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a-Tropomyosin (aTm) is central to Ca2+-regulation of cardiac muscle contraction. The familial
hypertrophic cardiomyopathy mutation aTm E180G enhances Ca2+-sensitivity in functional assays.
To investigate the molecular basis, we imaged single molecules of human cardiac aTm E180G by
direct probe atomic force microscopy. Analyses of tangent angles along molecular contours yielded
persistence length corresponding to 35% increase in ﬂexibility compared to wild-type. Increased
ﬂexibility of the mutant was conﬁrmed by ﬁtting end-to-end length distributions to the worm-like
chain model. This marked increase in ﬂexibility can signiﬁcantly impact systolic and possibly dia-
stolic phases of cardiac contraction, ultimately leading to hypertrophy.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
a-Tropomyosin (aTm) is a dimeric, a-helical coiled-coil protein
that binds actin and is an integral component of thin ﬁlaments for
Ca2+-regulated contraction of striated muscle. One troponin com-
plex (Tn) and one aTm molecule form a structural regulatory unit
with seven adjacent actin monomers in the thin ﬁlament, where
aTm binds to and spans all seven actins. The Ca2+ regulation mech-
anism of cardiac muscle contraction can be described by a three-
state model of regulatory units [1]. In the ‘blocked’ state, when
Ca2+ is effectively absent in the cytoplasm (cardiac diastole), aTm
sterically blocks myosin-binding sites on actin, inhibiting cross-
bridge formation and thus contraction. During systole, Ca2+ ions
are released from the sarcoplasmic reticulum and bind to Tn. Sub-
sequent conformational change of Tn leads to the ‘closed’ state, inchemical Societies. Published by E
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e).which azimuthal movement of aTm on the thin ﬁlament uncovers
part of myosin-binding sites on actin and allows formation of weak
cross-bridges. In the ‘open’ state, strong cross-bridge formation be-
tween myosin and actin is associated with further aTm movement
away from myosin binding sites, and full activation of regulatory
units. Activation of one regulatory unit may cooperatively inﬂu-
ence activation of adjacent regulatory units through end-to-end
interactions between adjacent aTmmolecules. Taken together, this
suggests that mechanical ﬂexibility of aTm is likely to be an essen-
tial parameter in this regulatory process within and between reg-
ulatory units, and thus could inﬂuence normal function of the
human heart [2,3].
Familial hypertrophic cardiomyopathy (FHC) is an inherited dis-
ease that affects 0.2% of the population [4]. It is typically charac-
terized by thickening of the myocardium and may be relatively
benign, or can lead to heart failure or sudden cardiac death [4]. Ge-
netic linkage studies have demonstrated that FHC is associated
with any of a large number of mutations, primarily in cardiac cyto-
skeletal proteins including thick ﬁlament proteins b-myosin heavy
chain, myosin essential and regulatory light chains, and cardiac
myosin-binding protein C, and thin ﬁlament proteins including
all three cardiac Tn subunits (cTnT, cTnI, and cTnC) and aTm [5–
11]. The E180G mutation in aTm is close to the primary cTnT bind-
ing site in the C-terminal end of the molecule. This missense muta-
tion leads to severe cardiac hypertrophy and early death in
transgenic mice [12]. At the molecular level, the mutant proteinlsevier B.V. All rights reserved.
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mal stability [13,14,16] compared to wild-type (WT) protein. In vi-
tro studies with mutant aTm using myoﬁbrillar ATPase activity,
motility assays and permeabilized cardiac cell mechanics showed
markedly enhanced Ca2+-sensitivity [6,17–19] and reduced func-
tional cooperativity [19]. A comparable increase in Ca2+-sensitivity
of actomyosin binding kinetics has also been reported with this
FHC-associated mutation of aTm [20].
A mechanistic relationship between the E180G mutation, the
above observations, and cardiac hypertrophy has not yet been
established, and more fundamentally there is no direct experimen-
tal information about the mutation’s effects on the structure and
mechanical properties of single aTm molecules. Modeling studies
suggest that the presence of, and variations in, myoﬁlament com-
pliance could alter myocyte function at all levels of Ca2+-activation
[21–24] and some aspects of muscle cell mechanics are most sim-
ply explained by Ca2+-dependent changes in sarcomere compliance
[25]. Estimates of thin ﬁlament ﬂexibility suggest that Tn and aTm
modulate compliance in a Ca2+-dependent manner [26] and this
could be directly inﬂuenced by ﬂexibility of aTm. We therefore
hypothesized that the E180G mutation alters the mechanical ﬂex-
ibility of aTm, which could contribute to functional differences be-
tween thin ﬁlaments containing the E180G mutant versus WT as
suggested by modeling studies on other FHC-related, thin ﬁlament
mutations [23].
Recently we reported the persistence length (Lp), which is a
measure of the rigidity of the molecule, of WT human cardiac
aTm [3]. Here we present the ﬁrst mechanical ﬂexibility measure-
ments of the E180G mutant using direct probe, atomic force
microscopy (AFM). The mutant is more ﬂexible than WT, with
35% shorter Lp. We propose that, corresponding to the increased
ﬂexibility, a lesser extent of Ca2+-induced conformational change
of Tn is required to perturb aTm to initiate thin ﬁlament activation
during systole, leading to enhanced Ca2+-sensitivity [2]. Hypersen-
sitivity to Ca2+ could overwork cardiac muscle, resulting in FHC.
Preliminary data were presented in an abstract [27].
2. Materials and methods
Experimental techniques were essentially as described in a pre-
vious publication [3] and are brieﬂy summarized below.
2.1. Protein preparation
WT human cardiac aTm cDNAwas cloned previously into a bac-
terial expression vector [28] and the E180G mutation was intro-
duced using site directed mutagenesis (Stratagene QuickChange
Kit, La Jolla, CA) [19]. Bacterial expression and puriﬁcation of re-
combinant mutant aTm was carried out as described.
2.2. Atomic force microscopy
Single molecules of E180G mutant aTm were imaged with a
MFP-3D (Asylum Research, Santa Barbara, CA) atomic force micro-
scope on poly-lysine (p-Lys) coated mica substrate. A 200 ll ali-
quot of 1 nM aTm E180G was deposited on the substrate and
incubated for 600 s; this incubation time was demonstrated to be
sufﬁcient for obtaining consistent estimates of Lp for WT aTm un-
der the same experimental conditions [3]. The sample was then
rinsed, and dried with compressed nitrogen gas. AFM images were
acquired at 0.5 nm/pixel in AC mode.
2.3. Image processing and data analysis
Images of individual aTmmolecules were processed with a cus-
tom routine developed in MATLAB (The MathWorks, Inc., Natick,MA) and the data were analyzed to yield Lp. Three separate meth-
ods of data analysis were applied to populations of aTm molecules
from independently prepared samples: second moment of tangent
angles, tangent angle correlation, and end-to-end length
distribution.
Brieﬂy, the shape of each aTm molecule was traced with sub-
pixel precision to obtain a polynomial skeleton representation of
the molecular contour. Angles, h(s), between the tangents of the
molecular contour at two points separated by segment length s
were computed in 0.5 nm steps. End-to-end length (Le–e) and con-
tour length (Lc) of each aTm molecule were calculated, respec-
tively, as the linear distance between the two ends of the
molecule and the integrated length along the polynomial ﬁt.
Equilibration of aTmmolecules on the substrate was veriﬁed by
the ratio between tangent angle fourth moment (<h4(s)>) and
squared second moment <h2(s)>2 [29] (Supplementary Materials).
Lp estimate was obtained by ﬁtting the dependence of <h2(s)> on




A zero intercept conﬁrmed that the molecules were equilibrated on
the substrate; the inverse of the slope gave Lp.
In tangent angle correlation analysis, the average of cosh(s),
<cosh(s)>, is assumed to be an exponential function of s:
< cos hðsÞ >¼ es=2Lp ð2Þ
<cosh(s)>, at a given s, was computed both along the contour of
each molecular skeleton and over different skeletons. Lp was ob-
tained by weighted linear regression on the logarithmically trans-
formed data.
A third estimate of Lp was obtained by analysis of end-to-end
length distributions. Scaled end-to-end length (le–e) was obtained
as the ratio between Le–e and Lc for each aTm molecule. Distribu-
tions of le–e were ﬁtted to that expected of a two-dimensional

















where lp = Lp/Lc, g is a normalization factor, and D3/2(x) is a para-
bolic cylinder function. In short, analyses of tangent angle second
moment, tangent angle correlation, and end-to-end length distri-
bution resulted in three independent estimates of Lp.
3. Results
Fig. 1A and the left-most collage in Fig. 1C show AFM scans of
aTm E180G on p-Lys coated mica. Lengths of clearly distinguish-
able elongated structures on the substrate are consistent with that
expected for single aTm molecules [31]. For comparison, p-Lys
coated mica (no aTm) is shown in Fig. 1B. In general, individual
molecules of aTm E180G appeared more bent in the images when
compared to WT (Fig. 1C). A small subset of mutant molecules
exhibits a noticeable kink along the molecular contour. As our spa-
tial resolution was limited by tip convolution and the N- and C-ter-
mini of the molecule were indistinguishable, we were not able to
quantitatively correlate the location of kinks in these molecules
with that expected for the E180G mutation along the molecular
contour (data not shown).
Fig. 2A shows the results of tangent angle second moment anal-
ysis of images obtained from three samples independently pre-
pared under identical experimental conditions. In this analysis, Lp
Fig. 1. AFM images of human cardiac aTm E180G molecules. (A) aTm E180G was imaged dry on poly-lysine coated mica. Lc of aTm E180G obtained from these images were
39.6 ± 0.1 nm (N = 537), 39.7 ± 0.1 nm (N = 1909), and 39.5 ± 0.1 nm (N = 589), consistent with that expected for single aTm molecules [31]. (B) Poly-lysine coated mica
substrate was imaged without the protein as control. (C) Collages of subsets of (left) E180G and (right) WT aTm molecules show that molecular contours were continuous,
although the mutant molecules appear more curved on average than the WT counterparts and some exhibit a noticeable kink.
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24.4 ± 0.2 nm (N = 537), 24.8 ± 0.1 nm (N = 1909), and
30.3 ± 0.2 nm (N = 589). The 5.9 nm difference between Lp values
of these samples represents experimental variations inherent to
our technique and this particular data analysis scheme, and is com-
parable to that in our previous measurements of WT aTm [3].
These values of Lp represent 37% decrease (corresponding to an
increase in ﬂexibility) compared to WT, which has Lp values of
39.5–44.5 nm. The values of <h2(s)> for E180G aTm are noticeably
different from those of WT for s >5 nm, and deviate somewhat from
a linear dependence on s, with a downward curvature, at s = 25–
30 nm. This indicates that the effect of the E180G mutation is not
localized at the mutation site and extends to most of the molecular
contour.
Tangent angle correlation analysis is shown in Fig. 2B. Lp values
obtained for the three samples of aTm E180G were 24.8 ± 0.5 nm
(N = 537), 25.2 ± 0.4 nm (N = 1909), and 31.9 ± 0.6 nm (N = 589).
These results agree very well with Lp estimates obtained with anal-
ysis of second moment, and again represents 37% decrease in
measured Lp compared to those of WT aTm. The 6.1 nm differ-
ence between the three samples is comparable to that in the anal-
ysis of tangent angle second moment.
To further verify our result, distributions of le–e from the same
samples were ﬁtted to the WLC model (Eq. 3). The resulting values
of lp obtained from the three samples of aTm E180G were
0.705 ± 0.060 (N = 537), 0.668 ± 0.041 (N = 1909), and
0.993 ± 0.060 (N = 589) (Fig. 3). Assuming 40 nm for the contour
length of aTm E180G (Fig. 1), the corresponding Lp values would
be 28.2 ± 2.4 nm, 26.7 ± 1.6 nm, and 39.7 ± 2.4 nm, respectively.The13 nm variation in Lp obtained with this analysis is consistent
with that previously reported for the WT protein [3]. Most impor-
tantly, this result represents a 34% decrease in measured Lp when
compared to the values for WT human cardiac aTm obtained with
the same analysis. This is in close agreement with the results ob-
tained from analyses of both <h2(s)> and correlation along molecu-
lar contour. We believe this drastic decrease in measured Lp is
unlikely to be fully accounted for solely by a change in inherent
curvature of the E180G mutant (Supplementary Materials). In
short, independent analyses of tangent angles and WLC ﬁtting of
the le–e distributions consistently indicate that the E180G mutant
is more ﬂexible than WT aTm at the single molecule level.
4. Discussion
In this study, we obtained AFM images of individual molecules
of human cardiac aTm E180G and measured their persistence
length. Tangent angle second moment, tangent correlation and
end-to-end length distribution resulted in Lp values of 24.4–
30.3 nm, 24.8–31.9 nm and 26.7–39.7 nm, respectively. Based on
the 35% smaller Lp value for the FHC-related E180G mutant rela-
tive to WT aTm, we conclude that the mutant is signiﬁcantly more
ﬂexible at the level of single molecules and suggest that this could
accentuate a local, spatial gradient of activation within a single
regulatory unit during systole, and could increase the likelihood
of diastolic dysfunction.
AFM images of clearly distinguishable, elongated structures
having lengths consistent with single molecules of aTm were ob-
tained on p-Lys coated mica surfaces. As shown previously, a large
Fig. 2. Lp by (A) tangent angle second moment analysis and (B) tangent angle
correlation analysis. Respective <h2(s)> and ln(<cosh(s)>) data obtained from three
aTm E180G samples independently prepared under identical conditions are plotted
as a function of segment length along the molecular contour. Regressions for WT
aTm [3] are replotted for comparison. Lp values for aTm E180G were 24.4 ± 0.2 nm
(N = 537, R2 = 0.99), 24.8 ± 0.1 nm (N = 1909, R2 = 0.99) and 30.3 ± 0.2 nm (N = 589,
R2 = 0.99) from the second moment analysis (Eq. 1) and 24.8 ± 0.5 nm (N = 537,
R2 = 0.97), 25.2 ± 0.4 nm (N = 1909, R2 = 0.98), and 31.9 ± 0.6 nm (N = 589, R2 = 0.98)
from the correlation analysis (Eq. 2).
Fig. 3. Lp by end-to-end length analysis. Normalized distribution of scaled end-to-
end length (le-e) from one of the E180G mutant samples (N = 1909). The mutant
distribution ﬁtted to the WLC model (Eq. 3) is signiﬁcantly broader (solid line) than
the WT counterpart (dotted line). The lp value for aTm E180G mutant from the ﬁt
was 0.67 + 0.04 (R2 = 0.82). Errors were estimated by the jackknife method.
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a semi-ﬂexible molecule such as aTm. Therefore, we analyzed the
contour shapes of 537–1909 molecules of aTm E180G from three
samples independently prepared under identical conditions, and
quantiﬁed their ﬂexibilities by three independent methods: tan-
gent angle second moment (Eq. 1), tangent correlation analysis
(Eq. 2), and end-to-end length distribution (Eq. 3). Fitting the
end-to-end length distribution to the WLC model (Eq. 3) resulted
in a slightly larger Lp compared to the tangent angle analyses
(Eqs. 1 and 2) for both mutant and WT proteins. All three analyses
showed a consistent 34–37% shorter Lp for aTm E180G compared
to the corresponding analyses for WT. In tangent angle second mo-
ment and tangent correlation analyses, the values of <h2(s)> and
ln <cosh (s)> for the E180G mutant are noticeably different from
that of the WT protein for s > 5 nm. Given that the E180G mutation
corresponds to a location 25 nm from the N-terminus of aTm,
most of the shorter segments (s < 20 nm) did not overlap with
the mutation site. This suggests that the E180G mutation impacts
the mechanical properties along most of the molecular contour
so that its effect is not localized at the mutation site. Values of< h2(s)> and ln <cosh (s)> for the E180G mutant also have a slight
downward curvature at s = 25–30 nm. As all longer segments
(s > 25 nm) contain the E180G mutation, this could reﬂect an alter-
ation to local structure near the E180G mutation.
The observed change in the measured Lp of human cardiac aTm
due to a single missense mutation seems drastic. It is possible that
this change is partly due to an altered intrinsic curvature of the
molecule. In the extreme case that the entire 35% reduction in
measured Lp was due to increased intrinsic curvature, it can be
estimated that the E180G mutant would have to be at least 80%
more bent compared to theWT protein (Supplementary Materials).
Such a large increase of inherent curvature in the E180G mutant is
unlikely and indeed inconsistent with our AFM images. Therefore,
we believe that the decrease in measured Lp of the E180Gmutant is
due to changes in both the inherent curvature and, likely more sig-
niﬁcantly, mechanical ﬂexibility of the molecule. Additional tech-
niques such as force spectroscopy are needed to reveal the
structural basis underlying the mutation-induced change in Lp.
During thin ﬁlament activation, aTm is mechanically displaced
following Ca2+-binding to the Tn complex to uncover myosin-bind-
ing sites of the underlying actin ﬁlament (Fig. 4). The reduced cor-
relation along the aTm molecule due to shorter Lp could decrease
binding cooperativity of aTm to adjacent actin monomers and thus
overall afﬁnity of aTm for F-actin [2], as observed for the E180G
mutant in the absence of Tn [5,13–15]. The functional regulatory
unit in normal cardiac muscle is shorter than a single aTm [32].
Our results lead to a prediction of further reduction in cooperative
transmission of activation along thin ﬁlaments containing aTm
E180G due to a spatial gradient of activation within partially acti-
vated, individual regulatory units during cardiac systole (Fig. 4),
and increased Ca2+-sensitivity of thin ﬁlament activation at low
Ca2+ due to lower energy of local displacement of aTm [2]; in addi-
tion, there could be a slight reduction in maximal force produced
by cardiac sarcomeres at saturating Ca2+ levels although this sce-
nario is unlikely in vivo. Higher Ca2+-sensitivity means that human
cardiac thin ﬁlaments harboring the FHC-related aTm E180G mu-
tant will become activated earlier during systole, remain activated
longer during the relaxation phase, and in extreme cases could
possibly stay partially activated during diastole [18,33,34]. FHC pa-
tients express both WT and mutant aTm and thus some heterodi-
mers are present [8,11]. Flexibility of a heterodimer is presumably
Fig. 4. Model of aTm motion within a partially activated, single regulatory unit of a
cardiac thin ﬁlament. This cartoon illustrates the proposed effect of increased aTm
ﬂexibility due to the E180G mutation on sub-saturating Ca2+-activation of cardiac
thin ﬁlaments. Structural details such as the coiling of aTm around F-actin, the
helical turns of actin, the span of Tn along the thin ﬁlament and its interactions with
actin are omitted for clarity. Due to the increased ﬂexibility, propagation of
activation signal along the length of aTm E180G will be impeded [2]. The mutant
has lower afﬁnity and non-cooperative binding to actin, thus a perturbation
requires smaller mechanical moment. Therefore, at low Ca2+, regulatory units on
thin ﬁlaments harboring mutant aTm are more likely to be activated compared to
WT, although there may be a local spatial gradient of partial activation.
C.K.P. Loong et al. / FEBS Letters 586 (2012) 3503–3507 3507between that of WT and mutant homodimers, although not neces-
sarily the average. In both cases, the increase in ﬂexibility would be
expected to have marked effects not only on the overall mechanics
of the heart and cardiac output, but also increased workload of car-
diac muscle en route to hypertrophy.
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